POULTRY NUTRITION

Mycotoxin-Induced Hepatic and Renal Stress Limits Vitamin D Activation

Vitamin D is one of the most critical nutrients influencing skeletal development, eggshell quality, immunity, hatchability, and overall productivity in poultry. However, the biological effectiveness of dietary Vitamin D depends on its successful conversion into active metabolites through hepatic and renal hydroxylation. Under commercial production conditions, mycotoxin exposure, among other stressors, can impair liver function and compromise this activation process, resulting in functional Vitamin D insufficiency despite adequate dietary supplementation.

Conventional dietary Vitamin D₃ (cholecalciferol) is biologically inactive when consumed. Before it can exert a physiological effect, it must undergo two sequential hydroxylation reactions: first in the liver, where it is converted to 25-hydroxycholecalciferol [25(OH)D₃], and then in the kidney, where it is further converted to 1,25-dihydroxycholecalciferol [1,25(OH)₂D₃], the biologically active form that binds to Vitamin D receptors and initiates cellular responses. This pathway depends entirely on healthy liver and kidney function, is metabolically time-intensive, involves conversion-associated nutrient losses, and becomes markedly less efficient under physiological stress. As a result, the amount of Vitamin D formulated into feed does not necessarily reflect the amount ultimately available to the bird in active form.

THE ACTIVATION PATHWAY

Two sequential, organ-dependent steps stand between feed and biologically active Vitamin D and both are vulnerable to mycotoxin damage.

These risks are compounded by the nature of mycotoxin contamination itself. Mycotoxins are heat-stable and survive pelleting and feed processing, so they are not eliminated in the mill. Commercial feed ingredients commonly carry more than one mycotoxin simultaneously, and the resulting performance losses are frequently subclinical eroding productivity well before any visible disease appears and often being misattributed to management or formulation inconsistencies. The following sections examine how specific mycotoxins disrupt the Vitamin D activation pathway, and how a bioactive Vitamin D source can offset that risk.

Mycotoxins are toxic secondary metabolites produced by fungi belonging primarily to the genera Aspergillus, Fusarium, and Penicillium. Due to their heat stability and resistance to feed processing, they remain one of the most persistent challenges in poultry nutrition. Subclinical exposure has been associated with reduced feed efficiency, poor nutrient utilization, compromised bone mineralization, inferior eggshell quality, reduced hatchability, increased susceptibility to disease, and poor flock uniformity. The challenge intensifies when multiple mycotoxins occur together a situation commonly observed in commercial feed ingredients. Among the organs affected, the liver is particularly vulnerable, and it is also the first and most critical site of Vitamin D activation.

As liver function declines under this toxic burden, the efficiency of Vitamin D activation decreases correspondingly. Birds may therefore experience reduced availability of active Vitamin D despite receiving adequate dietary supplementation a condition best described as functional Vitamin D insufficiency: Vitamin D is present in the diet but cannot be efficiently activated and utilized by the bird.

The consequences of this insufficiency are often progressive and difficult to diagnose. They include reduced bone mineralization and increased incidence of tibial dyschondroplasia and rickets, poor eggshell quality and shell strength, reduced hatchability and chick quality, impaired calcium and phosphorus utilization, reduced immune competence, poor growth performance, and reduced flock uniformity. In many commercial operations, these issues are attributed to management or nutritional inconsistencies while the underlying limitation in Vitamin D activation goes unrecognized.

Avitriol is a natural phytogenic feed supplement containing 1,25-dihydroxycholecalciferol [1,25(OH)₂D₃], the metabolically active form of Vitamin D₃, in plant-derived glycosidic form. Unlike conventional Vitamin D sources, Avitriol is already present in its active form and interacts directly with Vitamin D receptors without requiring prior activation in the liver or kidney. Because it bypasses both organs, its performance does not depend on hepatic health making it particularly relevant for flocks under mycotoxin pressure, disease challenge, or intensive production stress.

No activation steps. No organ dependence. No conversion losses.

Avitriol is already present in its active form, birds do not need to wait for hepatic and renal conversion before receiving Vitamin D activity supporting a rapid biological response and immediate nutritional support. It also removes the metabolic load that conventional Vitamin D sources place on the liver and kidney, organs that may already be challenged by mycotoxins, disease pressure, oxidative stress, or intensive production. The final active metabolite is delivered directly, Avitriol eliminates the conversion-associated losses that occur at each hydroxylation step in conventional metabolism.

The glycosidic form of Avitriol also enables a controlled, gradual release of the active metabolite, supporting consistent biological activity over time, while the product retains strong stability through pelleting and feed manufacturing preserving efficacy from feed mill to feeder.

Birds receiving Avitriol also showed significantly higher antibody titres against Newcastle Disease Virus than control and partially activated Vitamin D groups — evidence of stronger immune resilience under commercial conditions.

Source: Agrivet Research and Advisory Pvt. Ltd., Kolkata, India, Available on request.

 BENEFITS

Modern poultry production faces multiple challenges that can compromise nutrient utilization, with mycotoxin-induced hepatic stress representing one of the most significant yet often overlooked factors affecting Vitamin D metabolism. While conventional Vitamin D supplementation depends heavily on efficient liver and kidney function, Avitriol delivers a fundamentally different approach: as a plant-based source of bioactive 1,25(OH)₂D₃, it bypasses metabolic activation pathways, eliminates conversion-associated losses, imposes no metabolic burden on the liver and kidney, and provides immediate biological activity. In an era where maximizing nutrient efficiency is essential for profitability and sustainability, Avitriol ensures that birds receive not just Vitamin D, but the active Vitamin D they need to achieve optimal skeletal health, immunity, productivity, and overall performance.

 Avitriol — Plant-Based Bioactive Vitamin D₃